Unlearn.AI vs ChatGPT
Side-by-side comparison of AI visibility scores, market position, and capabilities
Unlearn.AI raised $50M+ for its digital twin technology that creates AI-generated control arms for clinical trials, reducing placebo group size and accelerating drug development timelines.
About
Unlearn.AI generates digital twins of clinical trial patients — AI models trained on historical trial data that predict how a specific patient would have responded as a placebo control. By supplementing small placebo control groups with these digital controls, pharmaceutical companies can run trials with fewer placebo patients (or none at all), reducing participant burden, trial costs, and development timelines without sacrificing statistical validity.
ChatGPT surpassed 400M weekly active users in February 2025 and launched GPT-4o with voice, image, and real-time reasoning — the world's most-used AI product.
About
ChatGPT is OpenAI's flagship AI assistant, launched in November 2022 and credited with igniting mainstream consumer adoption of generative AI. It crossed 100 million users in two months — the fastest consumer product to do so in history — and reached 400 million weekly active users by February 2025. Available as a free web and mobile app with a ChatGPT Plus subscription ($20/month) unlocking GPT-4o, advanced voice mode, image generation, and longer context.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.